Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 HKD | +0.70% | -8.90% | -37.59% |
16/05 | InnoCare Pharma Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis | CI |
14/05 | Innocare Pharma Posts Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.59% | 108.82Cr | |
+8.13% | 11TCr | |
+9.79% | 10TCr | |
-1.83% | 2.26TCr | |
-11.35% | 2.25TCr | |
-10.39% | 1.8TCr | |
-41.90% | 1.65TCr | |
-14.33% | 1.58TCr | |
+3.98% | 1.35TCr | |
+29.54% | 1.1TCr |
- Stock Market
- Equities
- 9969 Stock
- News InnoCare Pharma Limited
- InnoCare Pharma Launches HK$200 Million Share Buyback Plan